Amgen (NasdaqGS:AMGN) Declares US$2 Dividend Per Share For Q2 2025
Amgen (NasdaqGS:AMGN)'s recent affirmation of a $2.38 per share dividend for Q2 2025 could reflect investor confidence and ...
Amgen (NASDAQ:AMGN) Enters Late-Stage Testing on Weight Loss Drug
We know that weight loss drugs have been big winners for the companies that produce them. And now, biotech stock Amgen (AMGN) ...
Amgen Inc. (AMGN) 45th Annual TD Cowen Health Care Conference (Transcript)
Amgen Inc. (NASDAQ:AMGN) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ETCompany ParticipantsJay Bradner - Executive ...
AstraZeneca: A Big Pharma Blue Chip To Buy Now
AstraZeneca boasts a remarkably healthy drug portfolio and a pipeline of promising drugs in clinical development. Read why ...
News917h
Oklahoma Allergy and Asthma Clinic pushing back against insurance changes
The Oklahoma Allergy and Asthma clinic is pushing back against proposed changes in coverage for asthma medications covered by Blue Cross Blue Shield.
Piper Sandler healthcare analysts hold analyst/industry conference call
Healthcare Analysts discuss Amgen’s ( AMGN) Late-Stage Pipeline In The Rare Autoimmune Disease Arena on an Analyst/Industry conference call to be held on March 7. Published first on TheFly – the ...